[28-20-am] Pathophysiology (Oncology)

9:06 AM - 9:18 AM JST(12:06 AM - 12:18 AM UTC)

[28-20-am04] Evaluation of efficacy and hematologic toxicity of BRD4/CBP/p300 combined inhibition for pediatric MLL-rearranged acute lymphoblastic leukemia

○Natsuki Imayoshi^1,2, Kyona Yamamoto^1,3, Mio Shimada^1,3, Masahiro Tsuda^1,3, Tomohiro Terada¹, Eishi Ashihara² (1. Dept. Clin. Pharmacol. Ther., Kyoto Univ. Hosp., 2. Lab. of Clin. Transl. Physiol., Kyoto Pharmaceutical Univ., 3. Grad. Sch. Pharm. Sci., Kyoto Univ.)